Showing results 1 to 20 of 173
next >
| Issue Date | Title | Author(s) |
| Sep-2025 | 5-Year Analysis of the POLARIX Study: Prolonged Follow-Up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes | Salles, Gilles; Morschhauser, Franck; Sehn, Laurie H.; Herrera, Alex F.; Friedberg, Jonathan W.; Trneny, Marek; Lenz, Georg; Sharman, Jeff P.; Herbaux, Charles; Burke, John M.; Matasar, Matthew; Collins, Graham P.; Song, Yuqin; Pinto, Antonio; Rai, Shinya; Izutsu, Koji; Chohan, Saibah; Sugidono, Matthew; Jiang, Yanwen; Batlevi, Connie Lee; Yan, Mark; Tilly, Herve; Flowers, Christopher R. |
| Apr-2025 | Acalabrutinib Plus Bendamustine and Rituximab in Untreated Mantle Cell Lymphoma: The Phase 3 Echo Trial | Rule, Simon; Dreyling, Martin; Mayer, Jiri; Belada, David; Song, Yuqin; Jurczak, Wojciech; Paludo, Jonas; Chu, Michael P.; Kryachok, Irina; Fogliatto, Laura; Cheah, Chan; Morawska, Marta; Sancho, Juan Manuel; Li, Yufu; Patti, Caterina; Forsyth, Cecily; Zhang, Jingyang; Lesley, Robin; Ramadan, Safaa; Wang, Michael |
| 2009 | Adaptation analysis of artificial introduction of mangrove in Wenzhou, China | Song, Yuqin; Yuxi, Meng; Shaobo, Chen |
| 30-Mar-2024 | Adaptively leverage multiple real-world data sources for treatment effect estimation based on similarity | Long, Meihua; Song, Jiali; Rong, Zhiwei; Mi, Lan; Song, Yuqin; Hou, Yan |
| 25-Jun-2021 | Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma | Yu, Hui; Wang, Xing; Li, Jiao; Ye, Yingying; Wang, Dedao; Fang, Wei; Mi, Lan; Ding, Ning; Wang, Xiaogan; Song, Yuqin; Zhu, Jun |
| Dec-2021 | Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China | Zhang, Chen; Mi, Lan; Wu, Meng; Liu, Weiping; Ma, Hongmei; Ren, Jianxin; Zhao, Linjun; Wang, Xiaopei; Song, Yuqin; Zhu, Jun |
| Dec-2022 | Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China | Liu, Weiping; Ji, Jie; Zou, Dehui; Cao, Yang; Xu, Yajing; Zhou, Jian; Gao, Sujun; Wang, Fengrong; Chen, Wenming; Du, Juan; Zhou, Hui; Zhou, Fuling; Shi, Jimin; Zhang, Xi; Yang, Jianmin; Jing, Hongmei; Jiang, Zhongxing; Liu, Hui; Li, Caixia; Peng, Hongling; Jiang, Songfu; Wei, Xiaolei; He, Pengcheng; Liu, Yao; Yang, Haiyan; Li, Zengjun; Huang, Xiaobing; Liu, Lin; Shen, Lijing; Liu, Chuanfang; Song, Yuqin; Qiu, Lugui; Wang, Xiaopei; Ma, Jun; Zhu, Jun |
| 2018 | Baseline Characteristics of 3046 Non-Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP) | Song, Yuqin; Zhang, Huilai; Yang, Haiyan; Liu, Aichun; Cen, Xinan; Zhu, Jun; Wen, Yi |
| 2018 | Baseline Characteristics of 412 Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP) | Zhang, Huilai; Song, Yuqin; Liu, Aichun; Yang, Haiyan; Cen, Xinan; Zhu, Jun; Wen, Yi |
| 19-Jul-2025 | Bayesian biomarker effect estimate for combining data from multiple biomarker studies | Rong, Zhiwei; Song, Jiali; Sun, Fengyu; Zhang, Chenbo; Mi, Lan; Song, Yuqin; Hou, Yan |
| Jun-2025 | Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignancies | Broeckelmann, Paul J.; Cliff, Edward R. Scheffer; Iacoboni, Gloria; Simon, Florian; Horowitz, Mary M.; Keating, Armand; Mateos, Maria-Victoria; Mohty, Mohamad; Sidana, Surbhi; Song, Yuqin; Wingard, John R.; Thanarajasingam, Gita |
| 5-Nov-2024 | BRI05 Is a Novel Anti-Sirpa Monoclonal Antibody That Demonstrates a Favorable Safety Profile and Potent Anti-Tumor Efficacy in Patients with Relapsed/Refractory Lymphoid Malignancies: Preliminary Results from a Phase I Study | Lin, Ningjing; Du, Tingting; Zhou, Hui; Li, Yajun; Wang, Liang; Dong, Xiaomeng; Zheng, Haochuan; Lu, Jingtao; Tang, Mi; Wu, Jihua; Zhu, Wei; Song, Yuqin; Zhu, Jun |
| Nov-2022 | BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma | Eyre, Toby A.; Shah, Nirav N.; Dreyling, Martin; Jurczak, Wojciech; Wang, Yucai; Cheah, Chan Y.; Song, Yuqin; Gandhi, Mitul; Chay, Christopher; Sharman, Jeff; Andorsky, David J.; Messersmith, Hannah M.; Ruppert, Amy S.; Muthig, Valerie A.; Ito, Rodrigo; Wang, Michael L. |
| 2017 | The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages | Ping, Lingyan; Ding, Ning; Shi, Yunfei; Feng, Lixia; Li, Jiao; Liu, Yalu; Lin, Yufu; Shi, Cunzhen; Wang, Xing; Pan, Zhengying; Song, Yuqin; Zhu, Jun |
| 15-Apr-2022 | Burden of lymohoma in China, 1990-2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019 | Liu, Weiping; Liu, Jiangmei; Song, Yuqin; Wang, Xiaopei; Mi, Lan; Cai, Cai; Zhao, Donglu; Wang, Lijun; Ma, Jun; Zhu, Jun |
| 2018 | CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma | Ying, Zhitao; Wang, Wen; Wang, Xiaopei; Zheng, Wen; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Ping, Lingyan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Hao, Ming; Yang, Su; Zhou, Yan; Li, James; Song, Yuqin; Zhu, Jun |
| 5-Nov-2024 | CD93+Myeloid Cells Suppress T-Cell-Mediated Anti-Tumor Immunity | Yu, Hui; Qian, Yixin; Liu, Weiping; Mi, Lan; Huang, Yun; Peng, Rui; Cao, Jiaowu; Hu, Dingyao; Zhu, Jun; Song, Yuqin; Deng, Mi |
| Jul-2020 | Chemotherapy with a Pegylated Liposomal Doxorubicin-Containing Regimen in Newly Diagnosed Hodgkin Lymphoma Patients | Liu, Weiping; Yang, Mingzi; Ping, Lingyan; Xie, Yan; Wang, Xiaopei; Zhu, Jun; Song, Yuqin |
| 2017 | Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China | Shi, Yuankai; Jia, Bo; Xu, Wei; Li, Wenyu; Liu, Ting; Liu, Peng; Zhao, Weili; Zhang, Huilai; Sun, Xiuhua; Yang, Haiyan; Zhang, Xi; Jin, Jie; Jin, Zhengming; Li, Zhiming; Qiu, Lugui; Dong, Mei; Huang, Xiaobing; Luo, Yi; Wang, Xiaodong; Wang, Xin; Wu, Jianqiu; Xu, Jingyan; Yi, Pingyong; Zhou, Jianfeng; He, Hongming; Liu, Lin; Shen, Jianzhen; Tang, Xiaoqiong; Wang, Jinghua; Yang, Jianmin; Zeng, Qingshu; Zhang, Zhihui; Cai, Zhen; Chen, Xiequn; Ding, Kaiyang; Hou, Ming; Huang, Huiqiang; Li, Xiaoling; Liang, Rong; Liu, Qifa; Song, Yuqin; Su, Hang; Gao, Y |
| 2017 | Chimeric antigen receptor-modified T cells directed against CD19 in patients with relapsed or refractory CD19-positive B-cell lymphomas: interim analysis of a phase 1 study | Ying, Zhitao; Xiang, Xiaoyu; Song, Yuqin; Ding, Ning; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Liu, Yanling; Yue, Yunqiang; Yu, Xueyun; Liu, Hanzhi; Duan, Panpan; Mamuti, Mierzhati; Guo, Xiaokai; Chen, Feng; Wu, Xiaoyan; Zhang, Junqing; Zhang, Tingting; Huang, Xue F.; Jones, Lindsey; Kang, Xi; Chen, Si-Yi; Zhu, Jun |
